J-Pac Medical said it named former GI Supply finance chief Michael Dolge to be its new CFO and tapped Phil Littlefield, a medtech veteran, to be its vice president of operations.
Somersworth, N.H.-based J-Pac, which makes implantable textiles and offers packaging and manufacturing services to the medical device industry, said Dolge’s resume includes stints at Rohm & Haas, Goodrich, Johnson & Johnson (NYSE:JNJ) and Deloitte & Touche.
“We are at a critical juncture where there is a huge opportunity for J-Pac Medical to leverage its unique combination of value-added capabilities for implantable textiles, turnkey packaging, thermoformed packaging, and medical device manufacturing to increase our presence in additional markets and grow the company overall,” president & CEO Jeff Barrett, who joined the company in December 2015, said in prepared remarks. “This will require a strong leadership team, and bringing a seasoned CFO of Mr. Dolge’s caliber on board will be an invaluable asset to the company as we take J-Pac to the next level.”
“I am very impressed by what J-Pac has to offer the market and look forward to working closely with Mr. Barrett and the J-Pac team to optimize the company’s financial performance and help implement the company’s growth strategy,” Dolge added.
Littlefield has extensive experience in Lean/Six Sigma manufacturing, global supply chain and logistics management, and organizational development in FDA-regulated industries, J-Pac said.
“Mr. Littlefield is known for driving continuous improvement, implementing innovative game-changing processes and serving as a team mentor,” Barrett said. “These skills will make him a tremendous asset as we look to bolster J-Pac’s market presence as a contract provider of turnkey and thermoformed packaging, complete medical textile solutions and medical devices.”
“J-Pac has a unique combination of capabilities and extensive expertise that make it an ideal partner across a number of medical sectors,” added Littlefield. “I am excited to work with the team to optimize its operational processes so that we can maximize our value to our customers, as well as attract new business.”
Velano Vascular lures Smiths Medical’s Farrar for ops VP
Velano Vascular, having raised a $3.5 million funding round, named ex-Smiths Medical executive Quintin Farrar to be vice president of manufacturing & operations.
Presbia accounting chief Fogarty steps down
Presbia said its chief accounting officer, Richard Fogarty, plans to step down effective March 31, meaning an immediate search for his replacement.
Evolent Health rolls Stone into principal accounting officer spot
Evolent Health said it promoted managing director & corporate controller Lydia Stone to principal accounting officer back in January.
- Corindus names HeartFlow CMO Rogers to board
- Abiomed builds out board with Van Gorder, Rivet
- PerkinElmer CEO Friel, QualComm exec Rosenberg join NuVasive board
- ConforMIS to shift Fallon from Classs III to Class I director
- Potrero Medical puts WellMed CEO Rapier on board
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.